Transparency about pharma payments is often lacking the authors found underscoring concerns that the industry may be coopting U.K. patient groups. httpsbuff.ly2QndwNOÂ

Transparency about pharma payments is often lacking, the authors found, underscoring concerns that the industry may be co-opting U.K. patient groups. https://buff.ly/2QndwNO 

Transparency about pharma payments is often lacking, the authors found, underscoring concerns that the industry may be co-opting U.K. patient groups. https://buff.ly/2QndwNO 

More From BioPortfolio on "Transparency about pharma payments is often lacking, the authors found, underscoring concerns that the industry may be co-opting U.K. patient groups. https://buff.ly/2QndwNO "